Details about Samantha Lane
Access statistics for papers by Samantha Lane.
Last updated 2025-09-22. Update your information in the RePEc Author Service.
Short-id: pla1160
Jump to Journal Articles
Journal Articles
2025
- Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance
Drug Safety, 2025, 48, (9), 959-976 
2022
- Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data
Drug Safety, 2022, 45, (9), 1003-1008
Also in Drug Safety, 2022, 45, (11), 1439-1440 (2022)
2021
- How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Drug Safety, 2021, 44, (1), 1-5
- The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology
Drug Safety, 2021, 44, (8), 835-841
2020
- Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
Drug Safety, 2020, 43, (8), 809-821
- Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Drug Safety, 2020, 43, (7), 645-656 View citations (1)
|
The links between different versions of a paper are constructed automatically by matching on the titles.
Please contact if a link is incorrect.
Use this form
to add links between versions where the titles do not match.
|
EconPapers is hosted by the
School of Business at Örebro University.